Trials / Completed
CompletedNCT02867449
Metacognitive Therapy for Obsessive-Compulsive Disorder
A Non-Inferiority Trial of Metacognitive Therapy Versus Exposure and Response Prevention for Individuals With Obsessive-Compulsive Disorder
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 74 (actual)
- Sponsor
- University of Leipzig · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
Cognitive behavior therapy is the most effective treatment of obsessive-compulsive disorder. However, the majority of treated patients remain symptomatic. The metacognitive therapy by Wells (1997) could achieve substantial gains in first pilot studies. The purpose of this study is to investigate this approach with a randomized controlled trial by comparing metacognitive therapy with exposure and response prevention for obsessive-compulsive disorder.
Detailed description
The purpose of this study is to investigate metacognitive therapy by Wells (1997) with a randomized controlled trial by comparing metacognitive therapy with exposure and response prevention for obsessive-compulsive disorder.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Metacognitive Therapy | Metacognitive Therapy for OCD according to Wells (1997) |
| BEHAVIORAL | Exposure and Response Prevention | Exposure and Response Prevention for OCD according to Kozak \& Foa (1997) |
Timeline
- Start date
- 2016-06-01
- Primary completion
- 2020-01-01
- Completion
- 2020-01-01
- First posted
- 2016-08-16
- Last updated
- 2021-09-28
Locations
2 sites across 1 country: Germany
Source: ClinicalTrials.gov record NCT02867449. Inclusion in this directory is not an endorsement.